Remote Patient Monitoring System Market Size is valued at 26.64 billion in 2024 and is predicted to reach 87.64 billion by the year 2034 at a 12.8% CAGR during the forecast period for 2025-2034
COVID-19 has significantly impacted the Remote Patient Monitoring System industry. The enhanced chronic disease management provided by remote monitoring systems, including early warning indications and progress trackers, has increased demand for these systems on a global scale. 90% of yearly healthcare costs in the United States are attributable to chronic illnesses. This can be avoided if patients receive prompt assistance through a remote monitoring system.
Telemedicine software aids in digitizing and automating crucial tasks, which decreases hospital administrative tasks and increases product consumption; it can delay ER visits and hospitalizations. There is a space crunch in hospitals due to the COVID-19 pandemic. In addition, patients are cautioned against physically visiting hospitals due to the risk of contracting an infection, especially those with chronic illnesses. The global market was subsequently developed as a result. Businesses make significant investments by partnering, buying, and cooperating with newly emerging startups.
The market is categorized by component, indication, and end user. The component segment includes devices, software, and services. The devices category is further classified by function into cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal and neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, thermometers, and other monitoring devices; and by type into wearable, implantable, handheld & portable, and other devices.
The software segment is divided by deployment into on?premise models and cloud?based models, and by transmission into synchronous and asynchronous modes. The services segment covers telemedicine platforms and integrated RPM service models. Indications covered in the market include oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases such as COPD and asthma, wellness management, mental health, and other conditions. End users are segmented into healthcare providers (hospitals, ambulatory surgery centers/ambulatory care centers/outpatient settings, long?term care and assisted living facilities, home healthcare, and other healthcare providers) and other end users including healthcare payers, patients, pharmaceutical and biotechnology companies, MedTech companies, and others.
Diabetes became the dominant indication segment, contributing majorly in total revenue. Diabetes is one of the main reasons for death. Thus, blood glucose levels must be monitored constantly. It is known to impact several bodily processes, including kidney, liver, cardiac, and visual activities. As a result, routine and continuous monitoring is needed, which can be conveniently done with the help of RPM devices.
North America dominated the market globally and generated multiple substantial proportions of total revenue. The leading causes of the regional market growth are the rise in the prevalence of chronic diseases, the need for wireless and portable systems, and the availability of complex reimbursement schemes designed to reduce out-of-pocket expenses. Over the projected period, Europe, particularly the Western European nations, is anticipated to continue to rank second in terms of income generation.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 26.64 Bn |
|
Revenue forecast in 2034 |
USD 87.64 Bn |
|
Growth rate CAGR |
CAGR of 12.8% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Million, Volume (units), and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Component, Indication, And End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Honeywell; American Telecare; Roche; Philips Healthcare; Bosch; Biotronik; Intel; Welch Allyn; Health anywhere Inc.; Johnson & Johnson; Covidien Plc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Remote Patient Monitoring Market Snapshot
Chapter 4. Global Remote Patient Monitoring Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Remote Patient Monitoring Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on REMOTE PATIENT MONITORING MARKET Industry Trends
Chapter 5. Remote Patient Monitoring Market Segmentation 1: By Component, Estimates & Trend Analysis
5.1. Market Share by Component, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Component:
5.2.1. Devices
5.2.1.1. Function
5.2.1.1.1. Cardiac monitoring devices
5.2.1.1.2. Neurological monitoring devices
5.2.1.1.3. Respiratory monitoring devices
5.2.1.1.4. Blood glucose monitoring devices
5.2.1.1.5. Fetal & neonatal monitoring devices
5.2.1.1.6. Weight monitoring devices
5.2.1.1.7. Multiparameter monitoring devices
5.2.1.1.8. Pulse oximeter devices
5.2.1.1.9. Thermometers
5.2.1.1.10. Other monitoring devices
5.2.1.2. Type
5.2.1.2.1. Wearable devices
5.2.1.2.2. Implantable devices
5.2.1.2.3. Handheld & portable devices
5.2.1.2.4. Other devices
5.2.2. Software
5.2.2.1. Deployment Model
5.2.2.1.1. On-premise models
5.2.2.1.2. Cloud-based models
5.2.2.2. Transmission Type
5.2.2.2.1. Synchronous transmission
5.2.2.2.2. Asynchronous transmission
5.2.3. Services
5.2.3.1. Telemedicine platforms and integrated RPM service models
Chapter 6. Remote Patient Monitoring Market Segmentation 2: By Indication, Estimates & Trend Analysis
6.1. Market Share by Indication, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
6.2.1. Oncology
6.2.2. Cardiology
6.2.3. Neurology
6.2.4. Diabetes
6.2.5. Sleep disorders
6.2.6. Respiratory diseases (e.g., COPD, asthma)
6.2.7. Wellness improvement (weight management, personal health apps)
6.2.8. Mental health
6.2.9. Other indications
Chapter 7. Remote Patient Monitoring Market Segmentation 3: By End-Use, Estimates & Trend Analysis
7.1. Market Share by End-Use, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Use:
7.2.1. Hospitals
7.2.2. Ambulatory Surgery Centers (ASCs) / Ambulatory Care Centers (ACCs) / Outpatient settings
7.2.3. Long-term care & assisted living facilities
7.2.4. Home healthcare
7.2.5. Other healthcare providers
7.2.6. Other End Users
7.2.6.1. Healthcare payers (insurance, managed care)
7.2.6.2. Patients (self-monitoring, consumer use)
7.2.6.3. Pharmaceutical & bioComponent companies
7.2.6.4. MedTech companies
7.2.6.5. Other end users
Chapter 8. Remote Patient Monitoring Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Remote Patient Monitoring Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.2.3. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.2.4. North America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.3. Europe
8.3.1. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.3.3. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.3.4. Europe Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.4. Asia Pacific
8.4.1. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.4.3. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021- 2034
8.4.4. Asia Pacific Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.5. Latin America
8.5.1. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021- 2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.5.3. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.5.4. Latin America Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by country, 2021- 2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021- 2034
8.6.3. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021- 2034
8.6.4. Middle East & Africa Remote Patient Monitoring Market Revenue (US$ Million) Estimates and Forecasts by End-Use, 2021- 2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Alten Calsoft Labs (A Subsidiary Of Alten Group)
9.2.3. American Telecare; Roche;
9.2.4. Bio-Beat Technologies
9.2.5. Biotronik;
9.2.6. Bosch;
9.2.7. Boston Scientific Corporation
9.2.8. Cerner Corporation
9.2.9. Covidien Plc.,
9.2.10. Dexcom, Inc.
9.2.11. GE Healthcare
9.2.12. Health Anywhere Inc.;
9.2.13. Honeywell;
9.2.14. Intel;
9.2.15. Irhythm Technologies
9.2.16. Johnson & Johnson;
9.2.17. Medtronic
9.2.18. Omron Healthcare Inc.
9.2.19. Philips Healthcare;
9.2.20. Preventice Solutions
9.2.21. Resideo Life Care Solutions
9.2.22. Siemens Healthineers Ag
9.2.23. Teledoc Health Inc.
9.2.24. Vitalconnect
9.2.25. Vivalnk Inc
9.2.26. Vivify Health, Inc.
9.2.27. Welch Allyn (A Subsidiary Of Hill Rom Services, Inc.
Remote Patient Monitoring Market – By Component
Remote Patient Monitoring Market – By Indication
Remote Patient Monitoring System Market By End-Use-
Remote Patient Monitoring System Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
